The proliferating cell nuclear antigen (PCNA) is an auxiliary protein of DNA polymerase S and appears to be needed for both DNA synthesis and DNA repair. It is present in low amount in resting normal human T lymphocytes and, upon mitogenic stimulation with phorbol dibutyrate and ionomycin, begins to increase in mid-G1 phase, approximately 12 to 15 hours before entry into S phase. PCNA continues to increase in amount throughout the cell cycle and remains high in proliferating cultures. PCNA was extracted from activated normal T cells and from the transformed T-lymphoblastoid cell line Jurkat by a method that recovered approximately 98% of total cellular PCNA but yet retained its associations with other proteins. PCNA immunoprecipitates possessed H1 histone kinase activity, which increased in parallel with increasing cellular content of PCNA. Both the cdc2 and cdk2 kinases were found associated with PCNA in nor-T HE PROLIFERATING cell nuclear antigen (PCNA), previously called cyclin,' was discovered as a protein whose presence seemed to correlate highly with the growth status of cells.'-' Although this is generally true, several notable exceptions, such as high levels in a fraction of normal thymocytes4 and in Xenopus oocyte^,^ have indicated that the protein plays other roles than in cell proliferation itself. The finding that PCNA is an associated protein of DNA polymerase 6, which is involved in semiconservative DNA replication, may explain its presence in the nuclei of cells during the S phase of the cell It has been suggested that PCNA may help to stabilize the polymerase primedtemplate complex and function in leading strand elongation during DNA repli~ation.'.~ The finding that DNA polymerase 6 is also likely an enzyme that fills in excised nucleotides during the process of nucleotide excisionhepair after DNA damage'0." provides one explanation for the need for PCNA outside of the S phase of the cell c y~l e . '~"~ The recent observation that PCNA is also found associated with cyclidcyclin-dependent kinase complexes in human fibroblasts raises the possibility that it is involved in yet other cellular proce~ses.'~"~ Although the function of PCNA in these complexes remains unknown, the observations have taken on added significance with the suggestion that cellular transformation of fibroblasts results in significant alterations in the association of PCNA with certain of these molecules.'6 In the present report, we have examined the association of PCNA with cell-cycle regulatory molecules in mitogen-stimulated normal human T lymphocytes and in a T-cell-derived tumor cell line. As in fibroblasts, PCNA associates with all of the cyclin-dependent kinases and cyclins examined (ie, cdks 1, 2, 4, 5, and 6, and cyclins E, D2, and D3). Furthermore, PCNNcyclidcdk complexes possess protein kinase activity, which correlates with the presence of the two major H1 histone kinases, cdc2 and cdk2. However, the amount of these kinases associated with PCNA represents only a small pool of the total enzymes present in the cells. Surprisingly, most PCNA is found associated with those cdks, cdks 4, 5, and 6, which are perhaps most likely to play a role in regulating cell-cycle entry, early G1-phase progression, andor other functions not associated with progression through the proliferative cell as discussed below. Also it is shown that in nearly all aspects studied, the patterns of association of PCNA with the cdks and cyclins were similar for normal and transformed T lymphocytes.
T
HE PROLIFERATING cell nuclear antigen (PCNA), previously called cyclin,' was discovered as a protein whose presence seemed to correlate highly with the growth status of cells.'-' Although this is generally true, several notable exceptions, such as high levels in a fraction of normal thymocytes4 and in Xenopus oocyte^,^ have indicated that the protein plays other roles than in cell proliferation itself. The finding that PCNA is an associated protein of DNA polymerase 6, which is involved in semiconservative DNA replication, may explain its presence in the nuclei of cells during the S phase of the cell It has been suggested that PCNA may help to stabilize the polymerase primedtemplate complex and function in leading strand elongation during DNA repli~ation.'.~ The finding that DNA polymerase 6 is also likely an enzyme that fills in excised nucleotides during the process of nucleotide excisionhepair after DNA damage'0." provides one explanation for the need for PCNA outside of the S phase of the cell c y~l e . '~"~ The recent observation that PCNA is also found associated with cyclidcyclin-dependent kinase complexes in human fibroblasts raises the possibility that it is involved in yet other cellular proce~ses.'~"~ Although the function of PCNA in these complexes remains unknown, the observations have taken on added significance with the suggestion that cellular transformation of fibroblasts results in significant alterations in the association of PCNA with certain of these molecules. '6 In the present report, we have examined the association of PCNA with cell-cycle regulatory molecules in mitogen-stimulated normal human T lymphocytes and in a T-cell-derived tumor cell line. As in fibroblasts, PCNA associates with all of the cyclin-dependent kinases and cyclins examined (ie, cdks 1, 2, 4, 5, and 6, and cyclins E, D2, and D3). Furthermore, PCNNcyclidcdk complexes possess protein kinase activity, which correlates with the presence of the two major H1 histone kinases, cdc2 and cdk2. However, the amount of these kinases associated with PCNA represents only a small pool of the total enzymes present in the cells. Surprisingly, most PCNA is found associated with those cdks, cdks 4, 5, and 6, which are perhaps most likely to play a role in regulating cell-cycle entry, early G1-phase progression, andor other functions not associated with progression through the proliferative cell as discussed below. Also it is shown
Blood, Vol84, No 10 (November 15), 1994: pp 3413-3421 mal T cells, in amounts consistent with detected kinase activity. The results indicate that PCNA is not an inhibitory molecule of cdk/cyclin activity. Both normal and transformed T cells contained PCNA in association with cdk2, cdk4, cdk5, and cdk6, with the amount of PCNA associated with these molecules increasing in the order listed. Relatively high amounts of PCNA were also found associated with cyclins D2 and D3, the major cyclin partners of cdk6 in T cells. Though detected in normal cells, PCNAlcdQ complexes were present in exceedingly low amount, if at all. in Jurkat cells. This cell line appeared to contain more of nearly all of the cdk and cyclin molecules analyzed, but there seemed to be little difference in the patterns of association of these molecules with PCNA in the cell line as compared with normal human T cells. that in nearly all aspects studied, the patterns of association of PCNA with the cdks and cyclins were similar for normal and transformed T lymphocytes.
MATERIALS AND METHODS
Cell preparation and culture. Peripheral blood T cells isolated from healthy volunteers were used in all experiments. Mononuclear cell suspensions were prepared by Ficoll-Hypaque gradient centrifugation and T cells (E') were obtained by E-rosette enrichment. This population contained greater than 95% T cells as determined by immunofluorescence with anti-CD3 antibody?' Cells were cultured in RPM1 medium containing 10% (vol/vol) fetal calf serum (FCS) and 2 mmol/L glutamine. Jurkat cells2* were maintained in the same medium. As described in the text, T cells were activated by the addition of phorbol dibutyrate (PDB) (10 nmol/L) and ionomycin (0.5 mmoVL). PDB, obtained from Sigma (St Louis, MO), was dissolved at a concentration of IO-' mom in dimethyl sulfoxide (DMSO). Ionomycin, obtained from Calbiochem (San Diego, CA) was prepared as a 5-mmol/L stock solution in DMSO.
Immunoblot analysis. Cells were washed with phosphate-buffered saline (PBS) and then lysed at 4°C in RIPA buffer containing 25 mrnollL Tris-HC1, pH 7.4,50 mmol/L NaCl, 0.5% sodium deoxycholate, 2% Nonidet P-40, 0.2% sodium dodecyl sulfate (SDS), 1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 50 mg/mL aprotinin, 50 mmolL leupeptin, and 0.1 m m o K sodium ortho~anadate.~~ After removal of cellular debris by cenu$fugation, lysates were prepared for electrophoresis and polyacr$amide gel electrophoresis (PAGE) was performed as described by bemmli." When immuno-341 4 SZEPESI, GELFAND, AND LUCAS precipitates, prepared as described below, were to be analyzed by immunoblotting, they were resuspended in the Laemmli sample buffer"' and electrophoresis was performed as noted above. After electrophoretic transfer of proteins to nitrocellulose membranes (Hybond-ECL: Amersham, Arlington Heights, IL) and blocking of the filters with a solution containing bovine serum albumin:' filters were incubated with the appropriate primary antibody for 2 hours at room temperature. Appropriate secondary antibodies (1:5,000 dilution of either horseradish peroxidase-linked sheep antimouse immunoglobulin or donkey antirabbit immunoglobulin; Amersham) were then incubated with the membranes for 1 hour. The specific proteins were then detected using an enhanced chemiluminescence (ECL) method (Amersham).
For detection of the proteins analyzed, the following primary antibodies were used: cdc2, a mouse monoclonal antibody directed against a peptide comprising the C-terminal 15 amino acids of the protein (Zymed, San Francisco, CA); cdk2, a rabbit polyclonal antibody directed against a peptide comprising the C-terminal 12 amino acids of the protein (UBI, Lake Placid, NY); cdk4, a rabbit polyclonal antibody directed against a peptide comprising the C-terminal 16 amino acids of the protein (UBI); cdk5, a rabbit polyclonal antibody raised against a peptide corresponding to the carboxy-terminus region between amino acid residues 284 to 291 (Santa Cruz Biotech, Santa Cruz, CA); cdk6, a rabbit polyclonal antibody raised against a peptide corresponding to the carboxy terminus region between amino acid residues 306 to 326 (Santa Cruz Biotech); cyclin E, the mouse monoclonal antibody HE 12, prepared using recombinant cyclin E protein (Pharmingen, San Diego, CA); cyclin D2, a rabbit polyclonal antibody raised against a peptide corresponding to human cyclin D2 amino acid residues 274 to 290 (Santa Cruz Biotech); cyclin D3, the cyclin D3 antibody used for immunoblotting was a mouse monoclonal antibody purchased from Pharmingen; PCNA, either the mouse monoclonal antibody PC10 (Santa Cruz Biotech) or a PCNA-reactive human serum (a gift of Dr Yoshinari Takasaki, Tokyo, Japan); p53, the mouse monoclonal antibody DO-l , which is directed against the epitope comprising amino acid residues 37 to 45 and recognizes both wild-type and mutant human p53 proteins (Santa Cmz Biotech).
Immunoprecipitation of protein complexes. For isolation of protein complexes, a modification of the method of Howe et a13' was used. Cells were washed with cold PBS and then lysed in a buffer containing 50 mmol/L Tris-HC1, pH 7.4, 5 mmol/L EDTA, 250 mmol/L NaCI, 1 mmol/L PMSF, 20 p g l m L aprotinin, 10 pg/mL leupeptin, 100 pmol/L sodium orthovanadate, 50 mmol/L NaF, and 0.1 % Nonidet-P40 (NP-40 lysis buffer). To increase the extraction of nuclear proteins, the lysate was repeatedly extruded through a 25-G needle. Cell lysates were clarified by centrifugation in a microfuge for 15 minutes at 4°C and then precleared with protein Gsepharose beads (Zymed, San Francisco, CA) for 30 minutes. Immune complexes were then formed, for 2 hours at 4"C, with the same antibodies (with two exceptions) that were used above (for immunoblotting), at concentrations (generally 5 to 10 pg antibody per sample) determined to quantitatively immunoprecipitate the molecules of interest. For immunoprecipitation of cyclin D3, a rabbit polyclonal antibody (Santa Cruz Biotech) raised against a peptide corresponding to human cyclin D3 amino acid residues 277 to 292 was used; for cyclin E, the mouse monoclonal antibody HE 67 (Pharmingen) was used. After formation of the immune complexes, they were precipitated by addition of protein G-Sepharose beads. When the samples were to be analyzed by immunoblotting, they were washed five times with the NP-40 lysis buffer and then disrupted by heating for 5 minutes at 90°C in the Laemmli PAGE sample buffer. If the immunoprecipitates were to be used for determinations of histone kinase activity, they were processed as described in the next section.
Enzymatic assay $v cdk activity. P]-ATP, and incubated at 30°C for 15 minutes." All reactants were in excess and the reactions were stopped by addition of 5 xconcentrated SDS-containing electrophoresis sample buffer, while in a linear range of reaction. After heating at 90°C for 5 minutes and then cooling, the protein G-immunobeads were pelleted by centrifugation and proteins in the reaction mixtures were resolved by 12% PAGE. The proteins were then transferred electrophoretically to nitrocellulose membranes, a step that reduced background levels of radioactivity present throughout the gels. The radioactive histone HI bands were visualized by autoradiography and quantitated by phosphoroimage analysis.
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RESULTS
Induction of PCNA accumulation in normal human T lymphocytes. Normal human T lymphocytes were isolated from peripheral blood and activated in vitro using the combination of phorbol dibutyrate (PDB) and ionomycin. As described previo~sly,~~,'~ this combination of stimuli induces the most effective, rapid, and synchronous entry of T cells into and through the cell cycle. Entry into S phase is first detected at about 30 hours after treatme~~t.'~.~~ The synthesis of PCNA is regulated during the first cell cycle of normal human T lymphocytes induced to enter the cell cycle. It is present in low amount in normal quiescent cells and it has been reported that mitogens induce a coordinate synthesis of this protein and DNA,2~4,'4 although the induction of increased PCNA accumulation in normal T cells clearly precedes S-phase entry itself.'5 As shown in Fig 1, the 36-kD PCNA protein is present in low amounts in the resting cell population (0 time). However, increased accumulation of the protein is apparent as early as 15 hours after activation, some 15 hours before S-phase entry. The PCNA protein continues to increase in amount throughout the cell cycle, achieving maximal levels in the proliferating cell cultures (50 to 72 hours).
Efficiency of extraction of PCNA and associated molecules. In the work described below, the association of PCNA with a variety of other molecules will be demonstrated using the technique of coimmunoprecipitation. To perform this analysis, it is necessary to lyse cells and extract the molecules of interest under conditions that will maintain proteidprotein interactions existing in vivo. However, this entails the potential problem that specific pools of the molecules will not be effectively recovered. To assess the efficiency of extraction of PCNA and some of its associated molecules, the following analysis was performed. The conditions chosen for extract preparation"* were a modification of those used for preparation of enzymatically active complexes of the cdc2 and cdk2 cyclin-dependent kinases with their associated cyclins (ie, primarily cyclins A, B, and E) and were similar to those used by Xiong et a1'5~'h in their initial identification of PCNNcdk associations. Cells were disrupted by a solution containing the nonionic detergent NP- 40 needle. The residual nuclear/chromatin pellet and debris were removed by centrifugation. This pellet was normally discarded, but for estimation of the efficiency of recovery of PCNA. cdk2 and cdc2. as shown in Fig 2. the pellet was further extracted with a hot solution containing SDS. The entire residual nuclear extract and 2% of the original NP-40 cellular extract were subjected to PAGE and immunoblot analysis for the PCNA protein. Duplicate samples were analyzed for the cdk2 and cdc2 proteins. As shown in Fig 2, the PCNA signal detected for the entire nuclear extract was lower than that given by the initial lysate. indicating that at least 98% of the cellular PCNA content was recovered in the initial extraction. Similar results were observed for the cdk2 protein. The cdc2 protein seemed to be even more effectively extracted as the signal given after analysis of the nuclear pellet was even lower. The results shown in Fig 2 were obtained using cells harvested at 72 hours after stimulation, but similar results were obtained using cells harvested at other time points.
Detection of PCNA-associated HI histone kinase activity. The cdc2 and cdk2 kinases use the HI histone protein as an excellent substrate under the reaction conditions described in the Methods. Since both of these kinases have been reported to associate with PCNA in human fib rob last^.""^ the ability of the proteins coimmunoprecipitated with PCNA from normal and transformed (Jurkat) human T cells to phosphorylate HI histone in vitro was examined. As shown in 
(M) hrs
activity with time paralleled the overall increase in cellular PCNA content (Fig I ) . PCNA-associated HI histone kinase activity was also easily detectable in Jurkat cell extracts prepared from proliferating cells. As shown in the lower portion of Fig 3. when this activity was normalized to differences in cell number and cellular protein content of the normal and transformed cells. a s described in the legend to Here the HI histone kinase activity associated with cdc2, cdk2, and PCNA immunoprecipitates were directly compared. For this experiment. the same numbers and source (donor) of cells were used. The overall cdk2 activity in this 72-hour cell sample was approximately twice as high as the cdc2 content. The PCNA-associated activity was approximately 4% of the cdc2 value and 3% of the cdk2 activity. Although these PCNA-associated values are low. they do not preclude the possibility that they play ;I key role(s) in T-cell function. For comparison. it should be noted that the cyclin Ekdk2 kinase activity in normal T cells before Sphase entry is approximately 8% of the total cdk2 activity found in mid-S phase (Lucas et al. manuscript submitted); yet. it appears that this cyclin E-associated activity is essential for normal S-phase entry.'""''
Recent reports"'." have shown that the p2 I protein. which appears to be an inhibitor of cdk kinase activity.''.'" is often Extractability of the PCNA, cdk2, and cdc2 proteins under conditions that maintain intermolecular proteinlprotein associations. At 72 hours after activation with PDB/I, cells were harvested and three cell aliquots were disrupted using the NP-40 lysis buffer under the conditions described in the Methods. The residual chromatinlnuclear pellets were further extracted with a hot solution containing SDS. The entire chromatinlnuclear extracts and 2% of the initial NP-40 extracts were subjected t o PAGE followed by imrnunoblot analysis for the PCNA, cdkf, and cdc2 proteins. For each protein, lanes 1 and 2 show the results of analysis for the NP-40 and hot SDS extracts, respectively.
For growing Jurkat cells were also harvested. Cell extracts were prepared using the NP-40 lysis buffer and PCNA immunoprecipitates were isolated and then assayed for H1 histone kinase activity as described in the Methods. Duplicate 72-hour and Jurkat cell samples were also processed using a nonimmune antibody (C lanes). After the kinase reactions were halted, proteins were processed for gel electrophoresis and radiolabeled present, in normal fibroblasts, in quantenary complexes containing p21, PCNA, a cyclin, and a cdk. However. although many factors, including association with inhibitory molecules, may contribute to the low relative level of activity in PCNA immunoprecipitates, it appears that the major cause is that only small fractions of the total cellular cdc2 and cdk2 protein contents are in fact associated with PCNA in normal human T cells. This is demonstrated by the results presented in Fig S. The relative amount of cdc2 protein associated with PCNA was estimated by comparing the cdc2 present in a PCNA immunoprecipitate with that present in a cellular extract. As shown in Fig S, the signal generated by analysis of cdc2 in the PCNA immunoprecipitate is less than that seen when S% of an extract prepared from the same number of cells as used for the immunoprecipitation was analyzed. Assuming quantitative recovery of the coimmunoprecipitated cdc2, it can therefore be estimated that less than S% of the cellular cdc2 is associated with PCNA. Similar analysis of the cyclin E protein, also shown in Fig  S, indicated that a higher percentage of this molecule (>S%) was associated with PCNA. The relative amount of cdk2 associated with PCNA was estimated by an alternative method. In this case, the cdk2 protein was immunoprecipitated using a specific anti-cdk2 antibody. Aliquots representing either S or 40 million T cells were analyzed (lanes 7 and 8, respectively). As shown in Fig S, the amount of cdk2 directly isolated from S million cells was more than the amount of PCNA-associated cdk2 coimmunoprecipitated. using the anti-PCNA antibody, from 40 million cells (lane 9). Again. assuming efficient immunoprecipitation of the molecules, it can be concluded that less than 12.5% (5/30) of the cellular cdk2 content is in association with PCNA in the normal growing T cells. Since the low levels of PCNAassociated kinase activity correlate with low levels of the kinases themselves. it appears likely that PCNA does not play an inhibitory role in the multiprotein complexes in which it is found.
A.s.socinrion of PCNA 1tirh cyclir~-depet~det~r kirlcrses crnd cyclit1.s it1 t~onnnl hrrtrlcrt~ T cells. Since the amount of PCNA and its associated kinase activity were highest in proliferating cells, T cells harvested at 72 hours after activation were chosen for this analysis. The PCNA. cdc2. and cdk2 proteins were each immunoprecipitated using the conditions described above and excess antibodies specific for each protein. In addition. nonimmune mouse and rabbit antisera were used as controls for the cdc2 and cdk2 antibodies. respectively. The immunoprecipitates were then disrupted. subjected to PAGE, and analyzed for PCNA protein by immunoblotting. As shown in Fig 6. the PCNA immunoprecipitate contained a large quantity of the 36-kD immunoreactive protein, and no detectable signal was seen in the two control immunoprecipitates. The cdk2 immunoprecipitate contained an easily detectable amount of PCNA, and the cdc2 immunoprecipitate contained a substantially lower but still clearly detectable amount.
The analysis was then extended to include the other cdks. cdk4, S , and 6. The cdk3 protein was not included in this analysis as this protein has been difficult to routinely detect in normal human T cells (Lucas et al, unpublished data) . As shown in Fig 7. immunoprecipitates of all three of these cdks also contain the PCNA protein. In summary. the amount of PCNA appeared to be present in highest amount in the cdk6 immunoprecipitate. followed by cdkS. cdk4. cdk2. and cdc2. By comparison with results presented elsewhere and in Fig 9, below, this amount appeared not to correlate with the relative amount of the cdk proteins. It is also shown that PCNA can be coprecipitated with certain cyclins. such as cyclins D2 and D3. which are the two major cyclin partners of the cdk6 kinase in human T cells (Lucas et al, manuscript  submitted) .
Associntion of PCNA nit11 cyclin-clependent kincrses nncl cyclins in Jltrknt cells. The association of PCNA with the same cdks and cyclins examined in normal T cells was next examined in the transformed T-cell line Jurkat. In this analysis. rapidly growing log-phase cells were used for analysis.
As shown in Fig 8. PCNA was detected in association with cdks 2, 4, S, and 6, with increasing amounts found in the same order as for normal T cells. It was also present in immunoprecipitates of cyclin D2 and D3, with somewhat less found associated with cyclin D3 in the cell line as compared with in normal cells. As for normal T cells. PCNA was most difficult to detect in association with the cdc2 protein. 3) and cyclin E (lanes 4 through 61, cell pellets of T cells at 72 hours after activation were lysed with NP-40 lysis buffer, as described in the Methods. Immunoprecipitation was performed using antibody specific for PCNA (lanes 1 and 4) . The procedure was also performed using control (Cont 1P) antibodies from a nonimmune animal (lanes 2 and 5). The entire immunoprecipitates and aliquots representing about 5% of the total cell extracts (WC ext) were analyzed by immunoblotting (IB) for the cdc2 (lanes 1 through 3) and cyclin E (lanes 4 through 6) proteins. For analysis of cdk2 (lanes 7 through 91, a 72-hour T-cell pellet was lysed using NP-40 lysis buffer. The cdk2 was immunoprecipitated from this extract and aliquots representing either 5 or 40 x lo6 cells were analyzed (lanes 7 and 8, respectively) . The sample analyzed in lane 8 thus contains less heavy and light chain than that in lane 7. The cdk2 content associated with PCNA immunoprecipitated from 40 x lo6 cells was also detected (lane 9). The immunoprecipitates were analyzed by immunoblotting for the cdk2 protein, as described in the Methods. The positions of heavy chain (HC) and light chain (LC), contributed by the immunoprecipitating antibodies, are also indicated. These proteins are recognized by secondary antibody when the same species of antibody is used for both immunoprecipitation and immunoblotting. IB Ab, specificity of the antibody used in immunoblotting.
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The immunoprecipitates were analyzed for the PCNA -IP: cdc2 C l PCNA C2 cdk2 present in the transformed and normal cell types. the relative amounts of each of the proteins under study were compared by immunoblotting. a s shown in Fig 9. Here, the same amount of protein from an extract prepared from either growing Jurkat or (72 hours) normal human T cells were analyzed by immunoblotting. It was found that all of the cdks (cdc:!. and cdk2. 4. S. and 6) examined were in higher relative amounts in the cell line: cyclin D: ! was also in higher relative amount, whereas cyclins E and D3 appeared to be in lower relative amount in the cell line.
However, when ordered according to their ease of detection. there was a remarkable similarity in cellular content of the cell-cycle regulatory molecules between the two types. The apparent relative excess of most of the cell-cycle-related proteins in the cell line may be in part due to the fact that the entire population of Jurkat cells is in a rapidly growing phase. whereas the 72-hour population of normal cells contains small fractions of cells that have not properly progressed through their first G I phase or have heen rearrested in the cell cycle.
Since. as discussed below, the p53 protein appears to play an indirect role in negatively regulating cdk this protein was also examined (Fig 9) . Here. immunoblotting was performed using a monoclonal antibody that recognizes both wild-type and mutant p%. In the extract prepared from this sample of normal T cells. a doublet of immunoreactive proteins was detected. As we and others have noted preprotein by the technique of immunoblotting, as described in the Methods.
viou~ly."~." a portion of the human population is polymorphic for the p53 protein and displays such a protein doublet. No p53 protein was detected in the Jurkat cell line. which has previously been reported to have mutations in the pS3 gene:" The entire gel is shown to demonstrate that no discernible immunoreactive species was present.
DISCUSSION
The association of PCNA with the network of cdks and cyclins was first observed using human fibroblast cell types. including normal cell strains and transformed derivatives. which were shown to differ dramatically in their patterns of intermolecular ns~ocintions.""~ In the present report. this finding was extended to include normal human T lymphocytes induced to proliferate in vitro. However. our comparative analysis of normal and transformed T cells has. a s yet. shown little difference between the two cell types. either in the overall relative amounts of the proteins analyzed or in their patterns of association with PCNA.
One difference. an apparent lack of association of PCNA with cdc2 in the cell line. may be due to the fact that this is the most difficult of the complexes to detect in the lymphocyte system. Only small fractions of cdc? and PCNA seem to be associated with each other. even in normal T cells. A second difference, an apparent increased relative specific enzyme activity in the cell line as compared with normal l a n e 1 2 cells, may be due to the fact that the cell line contains a somewhat higher amount of some of the molecules (such a s cdk2) likely to be responsible for the observed HI histone kinase activity. Alternatively, considering our inability to clenrly detect cdc2 in the PCNA immunoprecipitates pmpared from Jurkat cells. this increased activity may reflect aberrant regulation of cdk2 activity in Jurkat cells. ;I possibility currently under investigation. This is of special interest as this cell line appears to lack the p53 protein. which has been recently shown to tr(~~~.s-activate a gene encoding a protein (p21 or the w a~l gene product) that suppresses the activity of cyclin-dependent kinases.'","" An inhibitory protein (p21) likely to be the w f -l protein in PCNA/cdk/cyclin complexes has been described."." The possible absence of this protein in Jurkat cells could therefore lead to aberrantly high levels of kinase activity in the complexes.
The relative fractions of all of the molecules (PCNA itself, cdks. and cyclins) present in PCNA/cdk/cyclin complexes appear to be small. The HI histone kinase activity associated with PCNA was also small, corresponding to the low levels of these proteins found in association with PCNA. A further contributing factor to the low levels of activity could also be the presence of inhibitory molecules, such as p21. although the presence of such factors was not described in the studies reported here. Definitive identification and analysis of these molecules awaits the preparation of appropriate immunologic reagents. As noted above. the low relative PCNAassociated kinase activity found does not preclude the possibility that it plays key role(s) in cellular function. To place into perspective the finding that generally less than S% of the molecules and activities studied were present in PCNAcontaining complexes. it is noted that the cyclin E/cdk2 activity of normal T cells before S-phase entry is less than 10% of maximal levels observed in mid-to late S phase (Lucas et al. manuscript submitted). Yet, it is likely that this cyclin E-associated activity is essential for S-phase entry.'""' It will be of interest to determine now whether these PCNAassociated fractions of cdks and cyclins are sequestered within specific areas of the cell. where low overall amounts of the molecules could yet be present in high concentration. Furthermore, it should be emphasized that among all of the molecules examined. PCNA appeared to be in lowest amount in complexes with cdc2 and cdk2. Finally. it is possible that the conditions used for cell lysis and extract preparation. though maintaining cdk/cyclin associations and enzyme activity. may yet partially disrupt the interaction of PCNA with these molecules. thus leading to low estimates of the extent of interaction of PCNA with other proteins.
The data indicate that most PCNA was associated with the cdk4. S, and 6 cyclin-dependent kinases. It will be necessary to determine the specific kinase activities of these enzymes when associated with PCNA. Conditions for directly assaying these molecules have only been developed recently,'.','5 since completion of the studies described here. In a recent analysis of the possible functions of the cdks.'" in which dominant negative mutants of each of the six cdks were expressed in cells. clear cell-cycle regulatory roles for only the cdc2. cdk2. and cdk3 proteins were demonstrated. Expression of the cdk4. S. and 6 mutants appeared to have no discernable effect on the cell lines used. Taken together with other extensive. but still indirect. evidence. it has been surmised that the closely related cdk4 and cdk6 proteins may play roles in cell-cycle entry and early progrcssion'""~''"' and that cdkS may be involved in or associated with the expression of certain differentiated phenotypes.'",'".'' Possible roles for PCNA in these processes remain to be determined. Also. as described here. PCNA was also in relatively high amount in association with cyclins D2 and D3. which are the major. if not only, cdk6 partners in normal T cells (Lucas et al. manuscript submitted). The normal cyclin partners for cdk5 in human T cells are unknown. although association of cdk5 in human fibroblasts with cyclins of the D family has been described. I5 Certain complexes of cdks and cyclins have been found to associate with other proteins as well. perhaps most notably with transcription factors such as E2F and the Rh protein (retinoblastoma susceptibility gene product) and their homologs and related molecules."x~~'"55 Rased on these observaFor personal use only. on October 30, 2017. by guest www.bloodjournal.org From tions, it has been proposed that active cdks may play an indirect role in the regulation of gene transcription. By analogy. a role for these kinases in DNA replication could also be proposed. However, more incisive molecular analysis, such as the determination of the precise sites in the cdks or cyclins required for PCNA binding and the preparation and expression of proteins mutated in these sites. will be required for an understanding of these possible roles. A recent report demonstrating binding of PCNA to cyclins D1 or D3 in the absence of other cellular factors suggests that PCNA association with cdks may be through its binding to cyclins.'" Last, it is suggested that direct comparisons between PCNAcontaining complexes isolated from various normal and transformed cell types, such as human fibroblasts and lymphocytes, will help to clarify the apparent differences described in the present report and previous studies.'." ACKNOWLEDGMENT Dr Kozo Takase is gratefully acknowledged for many helpful discussions and suggestions. Dr Yoshinari Takasaki (Juntendo University School of Medicine. Tokyo. Japan) is thanked for giving us the PCNA-reactive human serum. We also thank the personnel of the Children's Hospital Blood Donor Center (Denver. CO) for providing us with human blood.
